Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.22.1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
Schedule of reportable business segment information
Reportable business segment information is as follows (dollar amounts in thousands):

  Three Months Ended
March 31,
  2022 2021
Net sales:    
Asia $ 46,110  $ 35,755 
Europe 21,777  22,200 
North America 35,981  37,762 
Latin America and Other 6,626  6,704 
Total net sales 110,494  102,421 
Contribution margin (1):    
Asia 21,939  15,319 
Europe 4,373  6,796 
North America 12,719  15,440 
Latin America and Other 2,901  3,632 
Total contribution margin 41,932  41,187 
Selling, general and administrative expenses (2) 40,623  33,552 
Operating income 1,309  7,635 
Other loss, net (314) (1,933)
Income before provision for income taxes $ 995  $ 5,702 
_________________________________________

(1)    Contribution margin consists of net sales less cost of sales and volume incentives expense.
(2)    Service fees in China totaled $4.9 million and $2.8 million for the three months ended March 31, 2022, and March 31, 2021, respectively. These service fees are included in selling, general and administrative expenses.
Schedule of consolidated net sales revenue by geographical locations
From an individual country perspective, the United States and South Korea comprise 10 percent or more of consolidated net sales for the three months ended March 31, 2022 and 2021, as follows (dollar amounts in thousands):
 
  Three Months Ended
March 31,
  2022 2021
Net sales:    
United States $ 33,229  $ 34,920 
South Korea 13,653  14,809 
Other 63,612  52,692 
  $ 110,494  $ 102,421 
Schedule of revenue generated by each of the Company's product lines
Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):
 
  Three Months Ended
March 31,
  2022 2021
Asia    
General health $ 12,986  $ 11,292 
Immune 1,344  203 
Cardiovascular 13,630  9,903 
Digestive 9,036  6,871 
Personal care 2,543  2,524 
Weight management 6,571  4,962 
  46,110  35,755 
Europe    
General health $ 9,196  $ 9,472 
Immune 2,631  2,016 
Cardiovascular 2,633  2,992 
Digestive 5,591  5,540 
Personal care 1,233  1,426 
Weight management 493  754 
  21,777  22,200 
North America    
General health $ 15,314  $ 16,270 
Immune 4,872  4,874 
Cardiovascular 3,842  4,225 
Digestive 8,594  9,463 
Personal care 2,175  1,819 
Weight management 1,184  1,111 
  35,981  37,762 
Latin America and Other    
General health $ 1,818  $ 1,976 
Immune 761  811 
Cardiovascular 357  478 
Digestive 2,841  2,870 
Personal care 641  345 
Weight management 208  224 
  6,626  6,704 
  $ 110,494  $ 102,421 
Schedule of consolidated property, plant and equipment by geographical locations
From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
  March 31,
2022		 December 31,
2021
Property, plant and equipment:    
United States $ 45,769  $ 46,595 
Other 3,818  4,262 
Total property, plant and equipment, net $ 49,587  $ 50,857 
Schedule of assets per segment
Total assets per segment is set forth below (dollar amounts in thousands):
March 31,
2022		 December 31,
2021
Assets:    
Asia $ 93,957  $ 104,659 
Europe 14,233  15,486 
North America 122,779  131,207 
Latin America and Other 7,693  7,522 
Total assets $ 238,662  $ 258,874